These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 810574)
21. Behavioral activities and cardiovascular functions: effects of hexamethonium on cardiovascular changes during strong sustained static work in rhesus monkeys. Dews PB; Herd JA J Pharmacol Exp Ther; 1974 Apr; 189(1):12-23. PubMed ID: 4207241 [No Abstract] [Full Text] [Related]
22. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys. Vincent SH; Painter SK; Luffer-Atlas D; Karanam BV; McGowan E; Cioffe C; Doss G; Chiu SH Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401 [TBL] [Abstract][Full Text] [Related]
23. Effects of intravenous and aerosol administration of crude Shigella toxin to rhesus macaques: preliminary study. Liu CT; Sanders RP; Dominik JW; Formal SB Am J Vet Res; 1980 May; 41(5):836-9. PubMed ID: 6773452 [TBL] [Abstract][Full Text] [Related]
24. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys. Reuning RH; Ashcraft SB; Wiley JN; Morrison BE Drug Metab Dispos; 1989; 17(6):583-9. PubMed ID: 2575491 [TBL] [Abstract][Full Text] [Related]
25. Dietary protein intake influences the antihypertensive potency of methyldopa in spontaneously hypertensive rats. Sved AF; Goldberg IM; Fernstrom JD J Pharmacol Exp Ther; 1980 Jul; 214(1):147-51. PubMed ID: 7391965 [TBL] [Abstract][Full Text] [Related]
26. The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys. Fredericks AB; Benowitz NL; Savanapridi CY J Pharmacol Exp Ther; 1981 Feb; 216(2):247-53. PubMed ID: 6257883 [TBL] [Abstract][Full Text] [Related]
27. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
28. Disposition of DMP 811 (L-708,404), a potent angiotensin II receptor antagonist, in the rat, monkey, and chimpanzee. Zhang KE; Vyas KP Drug Metab Dispos; 1995 Oct; 23(10):1104-9. PubMed ID: 8654199 [TBL] [Abstract][Full Text] [Related]
31. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance. Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742 [TBL] [Abstract][Full Text] [Related]
32. Diastolic and systolic blood pressure measurements in monkeys determined by a noninvasive tail-cuff technique. Wiester MJ; Iltis R J Lab Clin Med; 1976 Feb; 87(2):354-61. PubMed ID: 812932 [TBL] [Abstract][Full Text] [Related]
33. Liquid chromatography/mass spectrometry for the quantitation of muraglitazar in monkey plasma. Yao M; Srinivas N Biomed Chromatogr; 2006 Oct; 20(10):1017-23. PubMed ID: 16506266 [TBL] [Abstract][Full Text] [Related]
34. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir. Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499 [TBL] [Abstract][Full Text] [Related]
35. Possible role of an endogenous opiate in the cardiovascular effects of central alpha adrenoceptor stimulation in spontaneously hypertensive rats. Farsang C; Ramirez-Gonzalez MD; Mucci L; Kunos G J Pharmacol Exp Ther; 1980 Jul; 214(1):203-8. PubMed ID: 6248627 [TBL] [Abstract][Full Text] [Related]
36. [Nycthemeral rhythm of blood pressure in labile hypertensive patients before and after administration of levo-alpha-methyldopa]. Bidoggia H; Koerner E; Durgan V; Fia C; Adet F Medicina (B Aires); 1969; 29(4):252-8. PubMed ID: 5382838 [No Abstract] [Full Text] [Related]
37. Determination of alpha-methyldopa and methyldopate in human breast milk and plasma by ion-exchange chromatography using electrochemical detection. Hoskins JA; Holliday SB J Chromatogr; 1982 Jun; 230(1):162-7. PubMed ID: 7202013 [No Abstract] [Full Text] [Related]
38. Stability-indicating high-performance liquid chromatographic assay for alpha-methyldopa in sustained-release capsules. Metwally M el-S J Chromatogr; 1991 Jul; 549(1-2):221-8. PubMed ID: 1770082 [TBL] [Abstract][Full Text] [Related]
39. Spurious increase in serum creatinine associated with intravenous methyldopate therapy. Nanji AA; Whitlow KJ Drug Intell Clin Pharm; 1984 Nov; 18(11):896-7. PubMed ID: 6499654 [TBL] [Abstract][Full Text] [Related]
40. Synthetic and preliminary hemodynamic and whole animal toxicity studies on (R,S)-, (R)-, and (S)-2-methyl-3-(2,4,5-trihydroxyphenyl)alanine. Musson DG; Karashima D; Rubiero H; Melmon KL; Cheng A; Castagnoli N J Med Chem; 1980 Dec; 23(12):1318-23. PubMed ID: 7452683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]